GemcitabineGemcitabine-related pneumonitis: 28 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1658卷 / 1期

关键词：

D O I：

10.1007/s40278-017-32408-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：211 / 211

相关论文

共 50 条

[1] AntineoplasticsImmune related pneumonitis: 2 case reports
Reactions Weekly, 2018, 1729 (1) : 28 - 28
[2] NivolumabImmune-related pneumonitis: 16 case reports
Reactions Weekly, 2023, 1946 (1) : 433 - 433
[3] Everolimus/temozolomideDrug related pneumonitis: 3 case reports
Reactions Weekly, 2016, 1588 (1) : 124 - 124
[4] AntineoplasticsImmune-related pneumonitis: 15 case reports
Reactions Weekly, 2020, 1808 (1) : 47 - 47
[5] NivolumabImmune-related pneumonitis: 2 case reports
Reactions Weekly, 2020, 1792 (1) : 175 - 175
[6] Ipilimumab/nivolumabImmune-related pneumonitis: 2 case reports
Reactions Weekly, 2020, 1813 (1) : 137 - 137
[7] Camrelizumab/tislelizumab/toripalimabCheckpoint inhibitor related pneumonitis: 3 case reports
Reactions Weekly, 2023, 1986 (1) : 120 - 120
[8] Multiple drugsImmune related liver injury and pneumonitis: 29 case reports
Reactions Weekly, 2020, 1810 (1) : 147 - 147
[9] Camrelizumab/doxorubicin/pembrolizumabImmune-related pneumonitis: 2 case reports
Reactions Weekly, 2020, 1798 (1) : 70 - 70
[10] Ipilimumab/nivolumabImmune related dermatitis, diverticulitis and pneumonitis: 3 case reports
Reactions Weekly, 2021, 1858 (1) : 214 - 214

← 1 2 3 4 5 →